Advertisement.

IMNPQ Projected Dividend Yield

Immune Pharmaceuticals Inc ( OTCBB : IMNPQ )

Immune Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of targeted therapeutics in the fields of immunology, inflammation, dermatology and oncology. Co.'s primary product candidate, bertilimumab, is a human monoclonal antibody, which targets eotaxin-1, a chemokine and has potential applications as a treatment for a variety of allergic and inflammatory diseases. Ceplene (histamine dihydrochloride), Co.'s primary oncology product candidate, is a small molecule, targeting the Histamine-2 Receptor, to be used in conjunction with low dose Interluken-2 to overcome immunosuppression in acute myeloid leukemia and potentially other malignancies.

20 YEAR PERFORMANCE RESULTS

IMNPQ Dividend History Detail
IMNPQ Dividend News
IMNPQ Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000